Fate Therapeutics, Inc. v. Shoreline Biosciences, Inc.
United States District Court, Southern District of CaliforniaOctober 12, 20233:22-cv-00676California858 words
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 FATE THERAPEUTICS, INC.; and Case No.: 22-cv-00676-H-MSB
WHITEHEAD INSTITUTE FOR
BIOMEDICAL RESEARCH, ORDER:
13 Plaintiffs, (1) GRANTING THE PARTIES’ 14 v. MOTIONS TO FILE DOCUMENTS UNDER SEAL;
SHORELINE BIOSCIENCES, INC.,
Defendant. [Doc. Nos. 394, 420, 421.] 17 (2) DIRECTING THE CLERK TO
FILE THE PROPOSED
DOCUMENTS UNDER SEAL; AND
20 [Doc. Nos. 395, 411, 412, 422.] 21 (3) ORDERING PLAINTIFFS TO
FILE PUBLICLY REDACTED
VERSION OF CERTAIN EXHIBITS
24 On September 14, 2023, Defendant Shoreline Biosciences, Inc. (“Shoreline”) filed 25 a motion for attorney’s fees. (Doc. No. 396.) On October 2, 2023, Plaintiffs Fate 26 Therapeutics, Inc. (“Fate”) and Whitehead Institute for Biomedical Research 27 (“Whitehead”) filed a response in opposition to Shoreline’s motion. (Doc. No. 413.) On 28 October 6, 2023, Shoreline…